source
- Biotech boards see more women, but CEO roles remain largely male-dominatedWomen now occupy roughly 29% of biotech board seats, a notable rise from about one‑fifth a few years ago, according to the latest Bedford Group Transearch report. Despite that progress, female CEO…
- Genetix’s genetic medicines are officially profitable, with $327M in sales YTDIt’s been a long road to financial stability for Genetix Biotherapeutics, the rebranded name of bluebird bio following its February 2025 sale to two private equity firms, but on Monday the biotech…BioSpace · 51m ago↗ source
- Marrow Therapeutics debuts with $173M to tackle blood disorders in vivo